Refocus Group is currently conducting clinical research studies using the PresVIEW™ Scleral Implant (PSI). These studies are designed to determine if implantation of the PSI device in the eye via the Scleral Spacing Procedure (SSP) will:

• Reduce or eliminate the need for corrective eyewear arising from presbyopia; and/or,
• Reduce intraocular pressure (IOP) to help treat glaucoma and ocular hypertension (OHT).

If you’re interested in learning more about SSP and/or establishing a clinical site for one of Refocus’s studies, click here.